Brief: Ashland Signs Definitive Agreement To Sell Nutraceuticals Business To Turnspire Capital Partners
May 7 (Reuters) - Ashland Inc ASH.N :
* ASHLAND SIGNS DEFINITIVE AGREEMENT TO SELL NUTRACEUTICALS
BUSINESS TO TURNSPIRE CAPITAL PARTNERS
Source text for Eikon: ID:nGNX9hMdHP
Further company coverage: ASH.N
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Ashland
See all newsEvonik remains opposed to takeover offer after meeting BASF, says source familiar with the matter
Evonik still against takeover by BASF after talks, Handelsblatt reports
Evonik remains opposed to BASF bid after meeting, says person familiar with the matter (updated)
BASF, Evonik management held talks over weekend, says person familiar with matter
US RESEARCH ROUNDUP-Cencora, Dave, Uber